Co-Investigator

 

 

 

Cardiology Co-Investigator

 

 

1) lAC-051-302: A Double-Blind, Placebo-Controlled, Multicenter, Randomized,
Parallel Design Study to Assess the Efficacy (Hemadynamics and Symptoms) of RO
G1-0612 (Tezosentan) in Patients with Acute Decompensated Heart Failure,
1999.

2) Managed Care Lipid Treatment Assessment Project (L-TAP) 1996.  

3) Angio-Seal Hemostatic Puncture Closure Device (IDEOG910028). 

4) Holmium Angioplasty Randomized Trial in Unstable Angina (1606).

5) NIR Vascular Advanced North American Trial (NIRVANA Trial) (1818).

6) SYMPHONY: A Phase III, Multicenter, International, Randomized, Double-Blind, Aspirin-Controlled Trial to Evaluate the Efficacy and Safety of Sibrafiban as Therapy for the Prevention of Secondary Vascular Events in Patients after Acute Coronary Syndromes (BC 15574A) (1853).

7) A Randomized Comparison of the ACS Rx Multi-Link) Corona Stent System with or without Abciximab vs. PTCA with or without Abciximab in the Treatment of Patients with Acute Myocardial Infarction (ACS 96-304). (1855).

8) Percutaneous Transluminal Myocardial Revascularization (1886).

9) A Multicenter Study of the Crossflex LC Balloon-Expandable Stent Mounted on the
Valor OTW Delivery System in Patients with De Novo or Restenotic Native Coronary
Artery or Saphenous Vein Graft Lesions.

10) A Single-Blind Randomized Study of the Safety and Effectiveness of Percutaneous
Transluminal Myocardial Revascularization (PTMR) Performed with the Eclipse:
Holmium Laser as an Adjunct to Percutaneous Coronary Intervention (TMR012-A,
Version 3.1) (1945).

11) Study of the Safety and Effectiveness of Percutaneous Transluminal Myocardial Revascularization in Patients with Class III or IV Angina (ITMR014) (1952).

12) The 2' SYMPHONY Trial. A Phase III, Multicenter, International Randomized,
Double-Blind, Aspirin-Controlled Trial to Evaluate the Efficacy and Safety of Two
Regimens with Xubix (Sibrafiban, Ro43-3657), an Oral Platelet Glycoprotein lib/Illa
Receptor Antagonist, as Therapy for the Long Term Prevention of Secondary
Vascular Events in Patients after an Acute Coronary Syndrome. (1955).

13) NIR Post Approval Study (1983).

14) A Phase II, Multicenter, Rndomized, Double Blind, Placebo-controlled Pilot Trial Evaluating the Effects of Infliximab(Remicade) in Patients with Stable Class III or IV Congestive Heart Failure.

 

 

Home ] Up ] Publications ] Abstracts ] Clinical Trials ] [ Co-Investigator ] [Contact Us] [Feghali Cardiology]


Copyright © 2003 Sayed Feghali Cardiology Association 
Last modified: June 21, 2003
ImageBuilders Web Site Design ImageBuilders Web Site Design